Physician profile
Maria E Lockhart
NPI 1801908249
$923.26
in general payments reported to CMS, 2019-2025
19 companies · $64.56 in 2025
The $64.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $77.28 · 2022: $90.67 · 2023: $89.66 · 2024: $17.64 · 2025: $64.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.59 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $267.36 | 2019-2020 | |
| Hologic Sales and Service, LLC | $126.91 | 2019-2023 | Myosure Tissue Removal Device |
| Exeltis, USA INC. | $77.09 | 2019-2020 | |
| Astellas Pharma US INC | $70.60 | 2019-2025 | Veozah |
| Daiichi Sankyo INC. | $61.02 | 2019 | |
| Pfizer INC. | $47.79 | 2023-2025 | |
| Allergan, INC. | $44.14 | 2019 | |
| Therapeuticsmd, INC. | $35.69 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $28.83 | 2023 | |
| Lupin INC. | $20.83 | 2019 | |
| Biogen, INC. | $19.44 | 2025 | Zurzuvae |
| Duchesnay USA Incorporated | $18.97 | 2019 | |
| Organon LLC | $18.41 | 2022-2023 | Nexplanon |
| Mission Pharmacal Company | $16.86 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.90 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.47 | 2019 | |
| Avion Pharmaceuticals | $13.91 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.98 | 2019 | |
| Merck Sharp & Dohme LLC | $12.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Lockhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.